Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001765581-23-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-07 | 2023-03-03 | JAZZ | GALA RENEE D | EVP, CFO | A - Grant | $0.00 | +12.8K | 45.3K | +39% | $0 | |
| 2023-03-07 | 2023-03-05 | JAZZ | GALA RENEE D | EVP, CFO | F - Tax | $142.78 | -1,557 | 43.8K | -3% | -$222.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-03 | A | A | 12,784 | $0.00 | 45,342 | D | — | — | |
| 2 | Common | Ordinary Shares | 2023-03-05 | F | D | 1,557 | $142.78 | 43,785 | D | — | — |